Classical and recent advances in the treatment of inflammatory bowel diseases
about
Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adultsThe relationship between the immune system and oral manifestations of inflammatory bowel disease: a reviewIndicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United StatesTLR2 and interleukin-10 are involved in Bacteroides fragilis-mediated prevention of DSS-induced colitis in gnotobiotic mice.Molecular mechanisms by which casein glycomacropeptide maintains internal homeostasis in mice with experimental ulcerative colitis.Pharmacokinetics in Wistar Rats of 5-[(4-Carboxybutanoyl)Amino]-2-Hydroxybenzoic Acid: A Novel Synthetic Derivative of 5-Aminosalicylic Acid (5-ASA) with Possible Anti-Inflammatory ActivityHydroalcoholic Extract from Inflorescences of Achyrocline satureioides (Compositae) Ameliorates Dextran Sulphate Sodium-Induced Colitis in Mice by Attenuation in the Production of Inflammatory Cytokines and Oxidative Mediators.Morinda citrifolia (Noni) Fruit Juice Reduces Inflammatory Cytokines Expression and Contributes to the Maintenance of Intestinal Mucosal Integrity in DSS Experimental Colitis.Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease Patients Stratified by Age.Development of a potential probiotic yoghurt using selected anti-inflammatory lactic acid bacteria for prevention of colitis and carcinogenesis in mice.Amelioration of experimental colitis after short-term therapy with glucocorticoid and its relationship to the induction of different regulatory markers.Anti-Inflammatory Effects of an Extract of Polygonum hydropiper Stalks on 2,4,6-Trinitrobenzenesulphonic Acid-Induced Intestinal Inflammation in Rats by Inhibiting the NF-κB Pathway.
P2860
Q26768280-1B94B00E-9869-4F2B-AA7D-2BCC85C4866EQ28078219-635787AA-F1ED-4EF5-AC1D-112B004DFC50Q33584629-37F539A2-9023-4716-B94B-FF508ED0C379Q33880555-7B8D513A-AB12-4DBD-8D13-B11464B12438Q33897813-200CAE0B-FF9D-40A1-BB1F-72A4E1F43A1AQ36084796-EE075C25-6DF5-48BB-83D1-398FAA0EAD82Q37399468-A0A85D31-31C5-4207-8CEB-9140908933CBQ38955023-2E88CCE1-BBDC-45CA-8257-6A38A16CAB62Q40378196-A0C8BEF5-44A1-44F2-8BCC-9D41E98AF6B2Q48186544-9C43BC14-1B38-4D99-8244-1DA0A9B951DBQ51517617-71C46FEE-B5E1-4A15-8375-6A22B53EF4FFQ55002814-47629061-162C-4744-AA24-39B56D9D33E0
P2860
Classical and recent advances in the treatment of inflammatory bowel diseases
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Classical and recent advances in the treatment of inflammatory bowel diseases
@ast
Classical and recent advances in the treatment of inflammatory bowel diseases
@en
Classical and recent advances in the treatment of inflammatory bowel diseases
@nl
type
label
Classical and recent advances in the treatment of inflammatory bowel diseases
@ast
Classical and recent advances in the treatment of inflammatory bowel diseases
@en
Classical and recent advances in the treatment of inflammatory bowel diseases
@nl
prefLabel
Classical and recent advances in the treatment of inflammatory bowel diseases
@ast
Classical and recent advances in the treatment of inflammatory bowel diseases
@en
Classical and recent advances in the treatment of inflammatory bowel diseases
@nl
P2093
P2860
P50
P921
P3181
P1476
Classical and recent advances in the treatment of inflammatory bowel diseases
@en
P2093
C R B Cardoso
V B F Alves
P2860
P304
P3181
P356
10.1590/1414-431X20143774
P407
P5008
P577
2015-02-01T00:00:00Z